care support program after diagnosis announcement: a dedicated time with a specialized nurse in announcement will be given tot the patient. The anxiety will also be evaluated
Study summary
The purpose of this study is to determine the impact on anxiety between patients with a period of care support following their announcement of an acute leukemia (AL) diagnosis and patients without this accompaniment.
Eligibility
Sex
ALL
Min age
26 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria:
* informed consent signed
* medical confirmation of acute leukemia diagnosis
* age equal of superior to 26 years and under 80 years
* confirmed diagnosis not yet treated
* hospitalization at Centre Henri Becquerel
* member or beneficiary of a social security
Exclusion Criteria:
* -Patient unable to understand the study for any reason or to comply with the trial's requirements
* Patient in relapse of acute leukemia
* Patient diagnosed with acute myeloid leukemia 3
* History of cancer within the 5 years preceding the year of study enrollment
* Alcohol and drug abuse
* Inclusion in another therapeutic trial that prevents further enrollment in a trial evaluating quality of life or psychological well-being
* Diagnosed psychiatric illness
* Patient under guardianship, curatorship, or legal protection
Primary outcome measure(s)
Anxiety improvment — 7 days after diagnosis announcement variation of anxiety level using STAI questionnaire
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
